1
|
Guzha BT, Matubu A, Nyandoro G, Mubata HO, Moyo E, Murewanhema G, Chirenje ZM. The impact of DNA tumor viruses in low-to-middle income countries (LMICS): A literature review. Tumour Virus Res 2024; 18:200289. [PMID: 38977263 PMCID: PMC11298656 DOI: 10.1016/j.tvr.2024.200289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2024] [Revised: 07/02/2024] [Accepted: 07/03/2024] [Indexed: 07/10/2024] Open
Abstract
DNA viruses are common in the human population and act as aetiological agents of cancer on a large scale globally. They include the human papillomaviruses (HPV), Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV), hepatitis viruses, and human polyomaviruses. Oncogenic viruses employ different mechanisms to induce cancer. Notably, cancer only develops in a minority of individuals who are infected, usually following protracted years of chronic infection. The human papillomaviruses (HPVs) are associated with the highest number of cancer cases, including cervical cancer and other epithelial malignancies. Hepatitis B virus (HBV) and the RNA virus hepatitis C (HCV) are significant contributors to hepatocellular cancer (HCC). Other oncoviruses include Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpes virus (KSHV), human T-cell leukemia virus (HTLV-I), and Merkel cell polyomavirus (MCPyV). The identification of these infectious agents as aetiological agents for cancer has led to reductions in cancer incidence through preventive interventions such as HBV and HPV vaccination, HPV-DNA based cervical cancer screening, antiviral treatments for chronic HBV and HCV infections, and screening of blood for transfusion for HBV and HCV. Successful efforts to identify additional oncogenic viruses in human cancer may provide further understanding of the aetiology and development of cancer, and novel approaches for prevention and treatment. Cervical cancer, caused by HPV, is the leading gynaecological malignancy in LMICs, with high age-standardised incidence and mortality rates, HCC due to HBV is an important cause of cancer deaths, and the burden of other cancer attributable to infections continues to rise globally. Hence, cancers attributable to DNA viruses have become a significant global health challenge. These viruses hence warrant continued attention and interrogation as efforts to understand them further and device further preventive interventions are critical.
Collapse
Affiliation(s)
- Bothwell Takaingofa Guzha
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe
| | - Allen Matubu
- University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe
| | - George Nyandoro
- Hepatitis Alliance, 2172, Arlington, Hatfield, Harare, Zimbabwe
| | - Hamish O Mubata
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe
| | - Enos Moyo
- School of Public Health Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
| | - Grant Murewanhema
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
| | - Zvavahera M Chirenje
- University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe; Department of Obstetrics, Gynecology and Reproductive Science, University of California San Francisco, San Francisco, USA
| |
Collapse
|
2
|
Sun Y, Tang D, Li N, Wang Y, Yang M, Shen C. Development of a Rapid Epstein-Barr Virus Detection System Based on Recombinase Polymerase Amplification and a Lateral Flow Assay. Viruses 2024; 16:106. [PMID: 38257806 PMCID: PMC10818573 DOI: 10.3390/v16010106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 01/06/2024] [Accepted: 01/08/2024] [Indexed: 01/24/2024] Open
Abstract
The quality of cellular products used in biological research can directly impact the ability to obtain accurate results. Epstein-Barr virus (EBV) is a latent virus that spreads extensively worldwide, and cell lines used in experiments may carry EBV and pose an infection risk. The presence of EBV in a single cell line can contaminate other cell lines used in the same laboratory, affecting experimental results. We developed three EBV detection systems: (1) a polymerase chain reaction (PCR)-based detection system, (2) a recombinase polymerase amplification (RPA)-based detection system, and (3) a combined RPA-lateral flow assay (LFA) detection system. The minimum EBV detection limits were 1 × 103 copy numbers for the RPA-based and RPA-LFA systems and 1 × 104 copy numbers for the PCR-based system. Both the PCR and RPA detection systems were applied to 192 cell lines, and the results were consistent with those obtained by the EBV assay methods specified in the pharmaceutical industry standards of the People's Republic of China. A total of 10 EBV-positive cell lines were identified. The combined RPA-LFA system is simple to operate, allowing for rapid result visualization. This system can be implemented in laboratories and cell banks as part of a daily quality control strategy to ensure cell quality and experimental safety and may represent a potential new technique for the rapid detection of EBV in clinical samples.
Collapse
Affiliation(s)
- Yidan Sun
- College of Life Sciences, Wuhan University, Wuhan 430072, China;
- China Center for Type Culture Collection, Wuhan University, Wuhan 430072, China; (D.T.); (N.L.); (Y.W.)
| | - Danni Tang
- China Center for Type Culture Collection, Wuhan University, Wuhan 430072, China; (D.T.); (N.L.); (Y.W.)
| | - Nan Li
- China Center for Type Culture Collection, Wuhan University, Wuhan 430072, China; (D.T.); (N.L.); (Y.W.)
| | - Yudong Wang
- China Center for Type Culture Collection, Wuhan University, Wuhan 430072, China; (D.T.); (N.L.); (Y.W.)
| | - Meimei Yang
- China Center for Type Culture Collection, Wuhan University, Wuhan 430072, China; (D.T.); (N.L.); (Y.W.)
| | - Chao Shen
- College of Life Sciences, Wuhan University, Wuhan 430072, China;
- China Center for Type Culture Collection, Wuhan University, Wuhan 430072, China; (D.T.); (N.L.); (Y.W.)
| |
Collapse
|